Reach Us +44-7482-864460
Regulation Of MiRNAs Expression By Mutant P53 Gain Of Function In Cancer | 86534
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Regulation of miRNAs expression by mutant p53 gain of function in cancer

Joint Event on 10th International Conference on Genomics and Molecular Biology & 6th International Conference on Integrative Biology

Tzitzijanik Madrigal Dominguez

UAM Iztapalapa, Mexico

Posters & Accepted Abstracts: J Mol Genet Med

DOI: 10.4172/1747-0862-C2-028

p53 is a tumor suppressor protein encoded by the TP53 gene which is located in chromosome 17p13.1. In response to environmental and cellular stress p53 activates the expression of genes and microRNAs (miRNAs) involved in cell cycle arrest, senescence and apoptosis. The TP53 is the most frequently mutated gene in human cancers. It has also been demonstrated that some mutant p53 proteins not only lose tumor suppressor activity, but also acquire novel oncogenic functions also known as “gain of function” (GOF) that are independent of wild-type (WT) p53. Recent studies have shown that mutant p53 can regulate gene expression and exert oncogenic effects through specific miRNAs. We transfected p53 mutants (p53R273, p53R175H, p53R248Q) into p53-null Saos2 cells, profiled the miRNA expression by miRNA PCR array, we selected and validated the expression of miR-182, miR-200b, miR- 3151 and miR-509-5p by real-time quantitative PCR and observed that mutants of p53 have a global negative effect for human miRNome expression, however some miRNAs were upregulated. Here we found tumor suppressors miRNAs downregulated like miR-200b, miR- 3151 and miR-509-5p or oncomiRNAs like miR-182 upregulated. Many studies have reported that patients with tumors carrying p53 mutations have worse prognosis and poorer response to conventional anticancer treatments that those bearing p53 WT protein, therefore, our study contributes to the understanding of regulation of miRNAs by mutants of p53 that could explain in part the role of mutant p53 proteins in the development of cancer and may help propose new target therapies.

Tzitzijanik Madrigal Domínguez completed her Graduation in Biology from Universidad Autonoma Metropolitana (UAM) in 2010; studied at Molecular Oncology Laboratory and received her MA in Experimental Biology from UAM in 2013. She is currently a PhD student in Experimental Biology Program-UAM. She is a Member of Mexican Association for Cancer Research which is a civil association, made up of scientists recognized both nationally and internationally as leaders in the development of basic, clinical, pharmacological and social research projects associated with the study of cancer..
Email:[email protected]